Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 2
1979 7
1980 10
1981 8
1982 12
1983 12
1984 14
1985 22
1986 26
1987 30
1988 26
1989 32
1990 27
1991 40
1992 62
1993 55
1994 69
1995 87
1996 85
1997 104
1998 125
1999 112
2000 159
2001 178
2002 214
2003 241
2004 328
2005 431
2006 503
2007 530
2008 740
2009 830
2010 906
2011 1126
2012 1285
2013 1625
2014 1883
2015 2129
2016 2197
2017 2347
2018 2700
2019 3044
2020 3613
2021 4034
2022 3459
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

31,822 results
Results by year
Filters applied: . Clear all
Page 1
Global prevalence and major risk factors of diabetic retinopathy.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY; Meta-Analysis for Eye Disease (META-EYE) Study Group. Yau JW, et al. Among authors: xu l. Diabetes Care. 2012 Mar;35(3):556-64. doi: 10.2337/dc11-1909. Epub 2012 Feb 1. Diabetes Care. 2012. PMID: 22301125 Free PMC article. Review.
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Shen Y, Liu YY, Chen C, Cheng Y, Xu L, Wang J, Fei K, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yan HH, Yang XN, Zhou Q, Wu YL; ADJUVANT investigators. Zhong WZ, et al. Among authors: xu l. Lancet Oncol. 2018 Jan;19(1):139-148. doi: 10.1016/S1470-2045(17)30729-5. Epub 2017 Nov 21. Lancet Oncol. 2018. PMID: 29174310 Clinical Trial.
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, Sun Y, Du X, Chi P, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Z, Zheng M, Xiao Y; RELARC Study Group. Xu L, et al. Lancet Oncol. 2021 Mar;22(3):391-401. doi: 10.1016/S1470-2045(20)30685-9. Epub 2021 Feb 12. Lancet Oncol. 2021. PMID: 33587893 Clinical Trial.
Melanopsin retinal ganglion cells mediate light-promoted brain development.
Hu J, Shi Y, Zhang J, Huang X, Wang Q, Zhao H, Shen J, Chen Z, Song W, Zheng P, Zhan S, Sun Y, Cai P, An K, Ouyang C, Zhao B, Zhou Q, Xu L, Xiong W, Zhang Z, Meng J, Chen J, Ma Y, Zhao H, Zhang M, Qu K, Hu J, Luo M, Xu F, Chen X, Xiong Y, Bao J, Xue T. Hu J, et al. Among authors: xu l. Cell. 2022 Aug 18;185(17):3124-3137.e15. doi: 10.1016/j.cell.2022.07.009. Epub 2022 Aug 8. Cell. 2022. PMID: 35944541
Corrigendum to Zhang J, Cai J, Cui Y, Jiang S, Wei J, Kim YC, Chan J, Thalakola A, Le T, Xu L, Wang L, Jiang K, Wang X, Wang H, Cheng F, Buggs J, Koepsell H, Vallon V, Liu R. "Role of the macula densa sodium glucose cotransporter type 1-neuronal nitric oxide synthase-tubuloglomerular feedback pathway in diabetic hyperfiltration." Kidney Int. 2022;101:541-550.
Zhang J, Cai J, Cui Y, Jiang S, Wei J, Kim YC, Chan J, Thalakola A, Le T, Xu L, Wang L, Jiang K, Wang X, Wang H, Cheng F, Buggs J, Koepsell H, Vallon V, Liu R. Zhang J, et al. Among authors: xu l. Kidney Int. 2022 Aug;102(2):448. doi: 10.1016/j.kint.2022.05.011. Kidney Int. 2022. PMID: 35870819 Free PMC article. No abstract available.
The monk parakeet (Myiopsitta monachus).
Huang Z, Xu L. Huang Z, et al. Among authors: xu l. Trends Genet. 2022 Sep;38(9):985-986. doi: 10.1016/j.tig.2022.06.010. Epub 2022 Jul 9. Trends Genet. 2022. PMID: 35820966 Free article. No abstract available.
Promising indicators for monitoring microplastic pollution.
Zhang Y, Wu H, Xu L, Liu H, An L. Zhang Y, et al. Among authors: xu l. Mar Pollut Bull. 2022 Sep;182:113952. doi: 10.1016/j.marpolbul.2022.113952. Epub 2022 Jul 28. Mar Pollut Bull. 2022. PMID: 35908487
Localized Nanopore Fabrication via Controlled Breakdown.
Ying C, Ma T, Xu L, Rahmani M. Ying C, et al. Among authors: xu l. Nanomaterials (Basel). 2022 Jul 12;12(14):2384. doi: 10.3390/nano12142384. Nanomaterials (Basel). 2022. PMID: 35889608 Free PMC article. Review.
31,822 results
You have reached the last available page of results. Please see the User Guide for more information.